Cordova-Pozo Kathya Lorena, Cordova-Pozo Graciela, Monza Ana, Píriz Gabriela, Moreno-Lopez Diva, Cardenas Ivan
South Group South Group Cochabamba Bolivia South Group, Cochabamba, Bolivia.
Hospital Seton Cochabamba Cochabamba Bolivia Hospital Seton, Cochabamba, Bolivia.
Rev Panam Salud Publica. 2017 Dec 5;41:e140. doi: 10.26633/RPSP.2017.140. eCollection 2017.
Compare World Health Organization (WHO) guidelines for contraception in a human rights framework with the existing regulatory frameworks of Bolivia, Colombia, and Uruguay and evaluate which aspects of those regulations need to be developed.
A systematic analysis was based on the WHO analytical framework "Ensuring human rights in the provision of contraceptive information and services: Guidance and recommendations" to determine whether the legislation of Bolivia, Colombia, and Uruguay contain general references to the population, specific references to adolescents, or do not refer to the topic. To this end, 36 documents related to contraception were analyzed: 9 from Bolivia, 15 from Colombia, and 12 from Uruguay.
It was confirmed that each country's legislation complies with several WHO recommendations. The three countries have strengths in nondiscrimination and in opportunity for informed decision-making, and have weaknesses in accessibility, quality, and accountability. Acceptability is a strength in Colombia and Bolivia, and confidentiality is a strength in Bolivia and Uruguay. Colombia has weaknesses in availability, confidentiality, and participation.
Comparison of national legislation with WHO guidance helps to see the strengths and weaknesses of national regulatory frameworks and to see opportunities to improve regulations.
在人权框架下,将世界卫生组织(WHO)的避孕指南与玻利维亚、哥伦比亚和乌拉圭的现行监管框架进行比较,并评估这些法规哪些方面需要完善。
基于WHO的分析框架“在提供避孕信息和服务中确保人权:指导意见和建议”进行系统分析,以确定玻利维亚、哥伦比亚和乌拉圭的立法是否包含对全体人群的一般性提及、对青少年的具体提及,或者是否未涉及该主题。为此,分析了36份与避孕相关的文件:9份来自玻利维亚,15份来自哥伦比亚,12份来自乌拉圭。
证实每个国家的立法都符合WHO的若干建议。这三个国家在非歧视和知情决策机会方面有优势,在可及性、质量和问责制方面存在不足。可接受性在哥伦比亚和玻利维亚是优势,保密性在玻利维亚和乌拉圭是优势。哥伦比亚在可获得性、保密性和参与方面存在不足。
将国家立法与WHO指南进行比较有助于了解国家监管框架的优势与不足,并发现完善法规的机会。